Research Progress of m6A Demethylase FTO and Its Inhibitors in Acute Myeloid Leukemia --Review / 中国实验血液学杂志
Journal of Experimental Hematology
; (6): 902-906, 2023.
Article
in Zh
| WPRIM
| ID: wpr-982148
Responsible library:
WPRO
ABSTRACT
Obesity-associated protein (FTO) is an important m6A demethylase that regulates RNA methylation modification and can promote the proliferation of acute myeloid leukemia(AML) cells. FTO regulates the methylation level of AML through multiple cellular signaling pathways such as FTO/RARA/ASB2, FTO/m6A/CEBPA, and PDGFRB/ERK, and participates in the occurrence, development, treatment and prognosis of AML. At present, studies have found that a variety of inhibitors targeting FTO have shown good anti-leukemia effects, and the study of FTO will provide new ideas for the treatment of AML. This review focus on the mechanism of action of FTO in AML and the research progress of FTO inhibitors in AML.
Key words
Full text:
1
Index:
WPRIM
Main subject:
Prognosis
/
Leukemia, Myeloid, Acute
/
Alpha-Ketoglutarate-Dependent Dioxygenase FTO
/
Methylation
Limits:
Humans
Language:
Zh
Journal:
Journal of Experimental Hematology
Year:
2023
Type:
Article